Erik Schropp

Erik Schropp

Director/Board Member presso POLYPEPTIDE GROUP AG

Patrimonio netto: 107 414 $ in data 31/03/2024

60 anni
Health Technology
Finance
Commercial Services

Profilo

Erik Schropp is currently the Chief Executive Officer at C&P Investors Ltd., Director at Haydn Holding AB, Non-Executive Director at PolyPeptide Group AG, Director at SEVER Life Sciences BV, Director at Draupnir Holding BV, Director at Svar Life Science AB, and Director at Ferring Foundation BV.
Previously, he worked as the Director-International Tax & Finance at Ferring Pharmaceuticals A, Director at Altacor Ltd., Director at PolyPeptide Laboratories Holding BV, Director at PolyPeptide Laboratories Holding (PPL) AB, and Director at FinVector Oy.
He also worked as the Manager-International Tax at Unisource NV and Tax Manager at Arthur Andersen Accountants.
Mr. Schropp graduated from Erasmus University Rotterdam in 1988.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/12/2022 3 193 ( 0.01% ) 107 414 $ 31/03/2024

Posizioni attive di Erik Schropp

SocietàPosizioneInizio
POLYPEPTIDE GROUP AG Director/Board Member 01/01/2021
C&P Investors Ltd. Chief Executive Officer 01/01/2020
Director/Board Member 01/01/2008
SEVER Life Sciences BV Director/Board Member 01/01/2019
Director/Board Member 01/01/2008
Haydn Holding AB Director/Board Member 01/01/2012
Director/Board Member 01/01/2008
Tutte le posizioni attive di Erik Schropp

Precedenti posizioni note di Erik Schropp

SocietàPosizioneFine
Director/Board Member 01/01/2021
Director/Board Member 01/01/2021
░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Erik Schropp

Formazione di Erik Schropp

Erasmus University Rotterdam Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Erik Schropp

Relazioni

65

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
POLYPEPTIDE GROUP AG

Health Technology

Aziende private13

Communications

Health Technology

Finance

Finance

Commercial Services

Haydn Holding AB

C&P Investors Ltd.

Health Technology

SEVER Life Sciences BV

Commercial Services

Commercial Services

Finance

Health Technology

Vedi le connessioni aziendali